Inventor
HAN XIAOCHUN
US22 patents
⚠️ This page may combine multiple inventors who share the name “HAN XIAOCHUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GILEAD SCIENCES INC
13 patentsUS11179397B2Nov 23, 2021
Imidazopyrimidine derivatives
GILEAD SCIENCES INC23 citations93
US11084832B2Aug 10, 2021
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC25 citations93
US11897892B2Feb 13, 2024
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC6 citations85
US12024528B2Jul 2, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC6 citations84
US11613546B2Mar 28, 2023
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC9 citations84
US11548902B1Jan 10, 2023
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC7 citations84
US12187734B2Jan 7, 2025
Substituted pyridotriazine compounds and uses thereof
GILEAD SCIENCES INC1 citations74
US12054496B2Aug 6, 2024
Bridged tricyclic carbamoylpyridone compounds and uses thereof
GILEAD SCIENCES INC2 citations72
US11352329B2Jun 7, 2022
HIV protease inhibitors
GILEAD SCIENCES INC3 citations71
US10774053B2Sep 15, 2020
HIV protease inhibitors
GILEAD SCIENCES INC4 citations71
US12227520B2Feb 18, 2025
Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use
GILEAD SCIENCES INC0 citations62
US8987250B2Mar 24, 2015
Therapeutic compounds
GILEAD SCIENCES INC3 citations61
US11352371B2Jun 7, 2022
Thienopyrimidine derivatives as ACC inhibitors and uses thereof
GILEAD SCIENCES INC0 citations47